[Tachyphylaxis].
D000818:Animals; D001427:Bacterial Toxins / Q000627:therapeutic use; D002648:Child; D004247:DNA / Q000627:therapeutic use; D004731:Endotoxins / Q000627:therapeutic use; D006168:Guinea Pigs; D006801:Humans; D007369:Interferon Inducers; D012157:Mononuclear Phagocyte System / Q000276:immunology; D009113:Muramidase / Q000096:biosynthesis; D010587:Phagocytosis; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use; D011353:Prodigiosin / Q000627:therapeutic use; D011414:Properdin / Q000096:biosynthesis; D012313:RNA / Q000494:pharmacology; D012141:Respiratory Tract Infections / Q000517:prevention & control; D012481:Salmonella Infections, Animal; D013618:Tachyphylaxis; D014436:Typhoid-Paratyphoid Vaccines; D014611:Vaccination; D015003:Yeasts / Q000032:analysis
D001427:Bacterial Toxins; D004731:Endotoxins; D007369:Interferon Inducers; D011135:Polysaccharides, Bacterial; D014436:Typhoid-Paratyphoid Vaccines; D011414:Properdin; D012313:RNA; D004247:DNA; D009113:Muramidase; D011353:Prodigiosin
Takhifilaksiia.